Quarterly report · Q1
3034.TEDINET S100ROAI
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥43.4bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥170.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥40.5bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥1.9bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥1.7bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.9bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥10.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.9bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.0bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.0bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.0bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥999m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥104.0bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥101.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥98.1bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥54.7bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥53.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥49.3bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥48.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥44.5bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.3bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥27.22 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥152.96 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.18 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 47.3% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥102m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥102m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥876m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥39.6bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥39.5bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥16m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥2.4bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥3.9bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥3.9bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥86m |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥327m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥43.5bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥43.4bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥102m |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥77m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥77m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥830m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥37.2bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥37.2bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥17m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥3.5bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥3.4bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥60m |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥349m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥40.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥40.5bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥77m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥2.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 351
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 1200200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | - | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 1200200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0308 | |
| Cash and deposits | Prior1YearInstant | 18770000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 19270000000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 16951000000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 15913000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 4990000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 6371000000 | JPY |
| Work in process | Prior1YearInstant | 90000000 | JPY |
| Work in process | CurrentQuarterInstant | 177000000 | JPY |
| Supplies | Prior1YearInstant | 205000000 | JPY |
| Supplies | CurrentQuarterInstant | 183000000 | JPY |
| Other ca | Prior1YearInstant | 3208000000 | JPY |
| Other ca | CurrentQuarterInstant | 4431000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -2000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -2000000 | JPY |
| Current assets | Prior1YearInstant | 44214000000 | JPY |
| Current assets | CurrentQuarterInstant | 46346000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 6818000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 7172000000 | JPY |
| Tools furniture and fixtures net | Prior1YearInstant | 1538000000 | JPY |
| Tools furniture and fixtures net | CurrentQuarterInstant | 1569000000 | JPY |
| Land | Prior1YearInstant | 6999000000 | JPY |
| Land | CurrentQuarterInstant | 6989000000 | JPY |
| Other net ppe | Prior1YearInstant | 751000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 611000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 16108000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 16342000000 | JPY |
| Goodwill | Prior1YearInstant | 32818000000 | JPY |
| Goodwill | CurrentQuarterInstant | 32905000000 | JPY |
| Software | Prior1YearInstant | 667000000 | JPY |
| Software | CurrentQuarterInstant | 740000000 | JPY |
| Other ia | Prior1YearInstant | 304000000 | JPY |
| Other ia | CurrentQuarterInstant | 229000000 | JPY |
| Intangible assets | Prior1YearInstant | 33790000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 33875000000 | JPY |
| Investment securities | Prior1YearInstant | 142000000 | JPY |
| Investment securities | CurrentQuarterInstant | 144000000 | JPY |
| Lease and guarantee deposits | Prior1YearInstant | 3942000000 | JPY |
| Lease and guarantee deposits | CurrentQuarterInstant | 3952000000 | JPY |
| Deferred tax assets | Prior1YearInstant | 2110000000 | JPY |
| Deferred tax assets | CurrentQuarterInstant | 1765000000 | JPY |
| Other ioa | Prior1YearInstant | 1616000000 | JPY |
| Other ioa | CurrentQuarterInstant | 1633000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -21000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -21000000 | JPY |
| Investments and other assets | Prior1YearInstant | 7791000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 7475000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |